Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes

被引：41
|
作者：
Preiser, Jean-Charles [1 ]
Provenzano, Bruna [1 ]
Mongkolpun, Wasineeart [1 ]
Halenarova, Katarina [1 ]
Cnop, Miriam [2 ,3 ]
机构：
[1] Free Univ Brussels, Dept Intens Care, Brussels, Belgium
[2] Free Univ Brussels, Erasmus Hosp, Div Endocrinol, Brussels, Belgium
[3] Free Univ Brussels, Ctr Diabet Res, Brussels, Belgium
来源：
ANESTHESIOLOGY | 2020年 / 133卷 / 02期
关键词：
COTRANSPORTER-2; INHIBITORS; CARDIOVASCULAR EVENTS; LACTIC-ACIDOSIS; BLOOD-GLUCOSE; METFORMIN; HYPERGLYCEMIA; DEATH; RISK; MORTALITY; SURGERY;
D O I：
10.1097/ALN.0000000000003237
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：430 / 438
页数：9
相关论文
共 50 条
  • [21] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
  • [22] Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes
    Rademaker, Doortje
    de Wit, Leon
    Duijnhoven, Ruben G.
    Voormolen, Daphne N.
    Mol, Ben Willem
    Franx, Arie
    Devries, J. Hans
    Painter, Rebecca C.
    van Rijn, Bas B.
    Siegelaar, Sarah E.
    Akerboom, Bettina M. C.
    Kiewiet-Kemper, Rosalie M.
    Verwij-Didden, Marion A. L.
    Assouiki, Fahima
    Kuppens, Simone M.
    Oosterwerff, Mirjam M.
    Stekkinger, Eva
    Diekman, Mattheus J. M.
    Vogelvang, Tatjana E.
    Belle-van Meerkerk, Gerdien
    Galjaard, Sander
    Verdonk, Koen
    Lub, Annemiek
    Klooker, Tamira K.
    Krabbendam, Ineke
    van Wijk, Jeroen P. H.
    Huisjes, Anjoke J. M.
    van Bemmel, Thomas
    Nijman, Remco G. W.
    van den Beld, Annewieke W.
    Hermes, Wietske
    Johannsson-Vidarsdottir, Solrun
    Vlug, Anneke G.
    Dullemond, Remke C.
    Jansen, Henrique J.
    Sueters, Marieke
    de Koning, Eelco J. P.
    van Laar, Judith O. E. H.
    Wouters-van Poppel, Pleun
    Evers, Inge M.
    Sanson-van Praag, Marina E.
    van den Akker, Eline S.
    Brouwer, Catherine B.
    Hermsen, Brenda B.
    Scholten, Ralph
    Meijer, Rick I.
    van Leeuwen, Marsha
    Wijbenga, Johanna A. M.
    Wijnberger, Lia D. E.
    van Bon, Arianne C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (06): : 470 - 478
  • [23] Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia
    Secnik, Juraj
    Xu, Hong
    Schwertner, Emilia
    Hammar, Niklas
    Alvarsson, Michael
    Winblad, Bengt
    Eriksdotter, Maria
    Garcia-Ptacek, Sara
    Religa, Dorota
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 86 (01) : 245 - 257
  • [24] Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
    Raparelli, Valeria
    Elharram, Malik
    Moura, Cristiano S.
    Abrahamowicz, Michal
    Bernatsky, Sasha
    Behlouli, Hassan
    Pilote, Louise
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (01):
  • [25] New glucose-lowering drugs for reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Gorgojo-Martinez, J. J.
    HIPERTENSION Y RIESGO VASCULAR, 2019, 36 (03): : 145 - 161
  • [26] Type 2 Diabetes: Assessing the Relative Risks and Benefits of Glucose-lowering Medications
    Bergenstal, Richard M.
    Bailey, Clifford J.
    Kendall, David M.
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (04): : 374.e9 - 374.e18
  • [27] Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids
    Sansome, Daniel J.
    Xie, Cong
    Veedfald, Simon
    Horowitz, Michael
    Rayner, Christopher K.
    Wu, Tongzhi
    DIABETES OBESITY & METABOLISM, 2020, 22 (02): : 141 - 148
  • [28] Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
    Funck, Kristian L.
    Knudsen, Jakob S.
    Hansen, Troels K.
    Thomsen, Reimar W.
    Grove, Erik L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (02): : 520 - 529
  • [29] Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
    Noh, Yoojin
    Jeon, Sang-Min
    Shin, Sooyoung
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (07) : 1530 - 1539
  • [30] Real world evidence of clinical predictors of glycaemic response to glucose-lowering drugs among Chinese with type 2 diabetes
    Wu, Hongjiang
    Lau, Eric S. H.
    Yang, Aimin
    Fan, Baoqi
    Ma, Ronald C. W.
    Kong, Alice P. S.
    Chow, Elaine
    So, Wing-Yee
    Chan, Juliana C. N.
    Luk, Andrea O. Y.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (04)
12345